“Successful Skin Cancer Screening Campaign Concluded by Charles SLBG Foundation and First Derm”
The Charles SLBG Foundation, in partnership with First Derm, has successfully completed a 30-month campaign to raise awareness and promote...
The Charles SLBG Foundation, in partnership with First Derm, has successfully completed a 30-month campaign to raise awareness and promote...
The number of children in private education has dropped by 10,000 over the past year as parents anticipate the introduction...
Wuppertal, Germany – Nexaro GmbH, a technology start-up based in Wuppertal, Germany, is pleased to announce its expansion into the...
ARTA 2024 Celebrates the Best of UK’s Pan Asian Cuisine London, UK – The winners of the annual Asian Restaurant...
Tuesday 8 October, 2024 Experts Urge Research into Population Screening and Targeted Surveillance for Childhood Cancer In a new review...
Last Updated on: CELLER8 is excited to announce the launch of two new additions to its PEMF therapy range: a...
The Confederation of British Industry (CBI) has urged Chancellor Rachel Reeves to introduce significant tax cuts for electric car, heat...
Madrid, Spain – Infinigate Iberia, a subsidiary of the Infinigate Group and a leading technology platform and trusted advisor in...
London, UK – The School and Public Health Nurses Association (SAPHNA) will be launching their significant report, ‘The Forgotten Frontline’,...
Copyright © 2025 InvestDailyPro. All Rights Reserved.
Disclaimer: InvestDailyPro.com, its managers, its employees, and assigns (collectively InvestDailyPro ) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.
The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.